Page 3 - Funding Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To embed, copy and paste the code into your website or blog: Welcome to your weekly update from the Allen & Overy Pensions team, covering all the latest legal and regulatory developments in the world of occupational pensions. This week we cover topics including: PSA21: response to consultation on employer resources test and information powers; TPR publishes 2021 Annual Funding Statement analysis; PASA: Counter fraud guidance; Data transfers: UK adequacy decision adopted; and HMRC newsletter 130. PSA21: response to consultation on employer resources test and information powers TPR publishes 20...

Here it is, our monthly digest of the most important pension articles Professional Pensions has written and published over the last month, along with some contextual notes.

Defined benefit (DB) pension schemes must stay alive to heightening risks to funding from sponsor covenants, climate change and longevity experience, The Pensions Regulator (TPR) says.

Ivermectin for COVID-19 in Peru: 14-fold reduction in nationwide excess deaths, p=.002 for effect by state, then 13-fold increase after ivermectin use restricted Posted on On May 8, 2020, Peru’s Ministry of Health approved ivermectin (IVM), a drug of Nobel Prize-honored distinction, for inpatient and outpatient treatment of COVID-19. As IVM treatments proceeded in that nation of 33 million residents, excess deaths decreased 14-fold over four months through December 1, 2020, consistent with clinical benefits of IVM for COVID-19 found in several RCTs. But after IVM use was sharply restricted...